EASTPHARMA LTD. EastPharma Ltd. reported consolidated earnings results for the six months ended June 30, 2015. For the period, the company reported revenue of USD 112,857,085 compared to USD 105,911,045 reported a year ago. Profit before tax was USD 9,689,053 compared to USD 157,459 reported a year ago.
Net profit for the period attributable to equity holders of the parent was USD 6,321,661 or USD 0.093 per basic and diluted share compared to USD 24 1,436 or USD 0.004 per basic and diluted share reported a year ago. Net cash provided by operating activities was USD 21,417,971 compared to net cash used in operating activities of USD 3,610,858 reported a year ago. Purchase of property, plant and equipment was USD 4,396,952 compared to USD 12,513,153 reported a year ago.
Purchase of intangible assets was USD 8,309,247 compared to USD 10,799,967 reported a year ago.
